PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.\', \'School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.\', \'Pediatric Intensive Care Department, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.\', \'Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.\', \'Internal Medicine Department, Infectious Diseases Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.\', \'School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. pedro.oliva@salud.madrid.org.\', \'Pediatric Intensive Care Department, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain. pedro.oliva@salud.madrid.org.\', \'Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain. alberto.borobia@salud.madrid.org.\', \'School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. alberto.borobia@salud.madrid.org.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04436-6
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32493475
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all